LIVZON PHARMA Publishes 2026 Q3 Report, Calls Second EGM and Unveils 2026-2028 Shareholder Return Plan

Bulletin Express10-23

On 23 October 2026, Hong Kong-listed Livzon Pharmaceutical Group Inc. (LIVZON PHARMA) released a package of corporate documents comprising:

• 2026 Third Quarterly Report • Circular dated 23 October 2026 • Notice and Proxy Form for the 2026 Second Extraordinary General Meeting (EGM) • Profit Distribution Proposal for the Third Quarter of 2026 • Shareholder Return Plan for 2026-2028

All materials are now available in both English and Chinese on the company’s website (www.livzon.com.cn) and on the Hong Kong Stock Exchange website (www.hkexnews.hk).

Shareholders whose holdings are maintained through CCASS and other intermediaries may register an e-mail address with their broker, bank, custodian, or nominee to receive electronic notifications when future corporate communications are published. Those unable to access the online versions can obtain printed copies free of charge by submitting the enclosed request form to Tricor Investor Services Limited at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong, or by e-mailing 1513-ecom@vistra.com.

The company secretary, Liu Ning, signed the notification on behalf of the board. For enquiries, shareholders may contact Tricor’s hotline at +852 2980 1333 during business hours, Monday to Friday (excluding public holidays).

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment